Cargando…
Fibroblast growth factor 23 level modulates the hepatocyte’s alpha-2-HS-glycoprotein transcription through the inflammatory pathway TNFα/NFκB
INTRODUCTION: High serum levels of fibroblast growth factor 23 (FGF23) characterize chronic kidney disease (CKD) since its early stages and have been suggested to contribute to inflammation and cardiovascular disease. However, the mechanisms linking FGF23 with these pathological conditions remain st...
Autores principales: | Mattinzoli, Deborah, Li, Min, Castellano, Giuseppe, Ikehata, Masami, Armelloni, Silvia, Elli, Francesca Marta, Molinari, Paolo, Tsugawa, Koji, Alfieri, Carlo Maria, Messa, Piergiorgio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769965/ https://www.ncbi.nlm.nih.gov/pubmed/36569120 http://dx.doi.org/10.3389/fmed.2022.1038638 |
Ejemplares similares
-
Possible Benefits of a Low Protein Diet in Older Patients With CKD at Risk of Malnutrition: A Pilot Randomized Controlled Trial
por: Caldiroli, Lara, et al.
Publicado: (2022) -
MCP1 Could Mediate FGF23 and Omega 6/Omega 3 Correlation Inversion in CKD
por: Mattinzoli, Deborah, et al.
Publicado: (2022) -
FGF23 and Fetuin-A Interaction and Mesenchymal Osteogenic Transformation
por: Mattinzoli, Deborah, et al.
Publicado: (2019) -
Carbon dots conjugated to SN38 for improved colorectal anticancer therapy
por: Mattinzoli, Deborah, et al.
Publicado: (2022) -
FGF23 and Fetuin-A Interaction in the Liver and in the Circulation
por: Mattinzoli, Deborah, et al.
Publicado: (2018)